相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders
Astrid Guldbrandsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study
Claire L. Russell et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2017)
Expanding the cerebrospinal fluid endopeptidome
Karl T. Hansson et al.
PROTEOMICS (2017)
Multiple reaction monitoring assay based on conventional liquid chromatography and electrospray ionization for simultaneous monitoring of multiple cerebrospinal fluid biomarker candidates for Alzheimer's disease
Yong Seok Choi et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Myles R. Minter et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint
Nikita Rudinskiy et al.
ALZHEIMERS & DEMENTIA (2016)
Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
Fabio Di Domenico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
Nicolas R. Barthelemy et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
Josef Pannee et al.
JOURNAL OF NEUROCHEMISTRY (2016)
CSF N-glycoproteomics for early diagnosis in Alzheimer's disease
Angelo Palmigiano et al.
JOURNAL OF PROTEOMICS (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave et al.
MOLECULAR NEURODEGENERATION (2016)
Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
Payam Emami Khoonsari et al.
PLOS ONE (2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
Annika Ohrfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Simon Sjodin et al.
CLINICAL PROTEOMICS (2016)
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
Hlin Kvartsberg et al.
ALZHEIMERS & DEMENTIA (2015)
Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants
Erin E. Franklin et al.
ALZHEIMERS & DEMENTIA (2015)
Explorative and targeted neuroproteomics in Alzheimer's disease
Ann Brinkmalm et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease
Erik Portelius et al.
BRAIN (2015)
Dickkopf-related protein 3 is a potential Aβ-associated protein in Alzheimer's Disease
Kim A. Bruggink et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration
Magnus Rogeberg et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Wendy E. Heywood et al.
MOLECULAR NEURODEGENERATION (2015)
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Ronald C. Hendrickson et al.
PLOS ONE (2015)
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
Daniel S. Spellman et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls
Hlin Kvartsberg et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry
Pauline Bros et al.
FRONTIERS IN NEUROSCIENCE (2015)
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Mikko Holtta et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
Eduardo Martinez-Morillo et al.
ACTA NEUROPATHOLOGICA (2014)
Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry
Thomas McAvoy et al.
CLINICAL CHEMISTRY (2014)
Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid
Andreas Leinenbach et al.
CLINICAL CHEMISTRY (2014)
Assessment of Peptide Chemical Modifications on the Development of an Accurate and Precise Multiplex Selected Reaction Monitoring Assay for Apolipoprotein E Isoforms
Eduardo Martinez-Morillo et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Intact Protein Analysis of Ubiquitin in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Differences in Alzheimer's Disease and Frontotemporal Lobar Degeneration
Patrick Oeckl et al.
JOURNAL OF PROTEOME RESEARCH (2014)
In-depth Characterization of the Cerebrospinal Fluid (CSF) Proteome Displayed Through the CSF Proteome Resource (CSF-PR)
Astrid Guldbrandsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics
Kristin R. Wildsmith et al.
MOLECULAR NEURODEGENERATION (2014)
Role of fibulin-3 in lung cancer: In vivo and in vitro analyses
Shun Xu et al.
ONCOLOGY REPORTS (2014)
Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics
Kwasi G. Mawuenyega et al.
ANALYTICAL BIOCHEMISTRY (2013)
Targeted Quantitation of Proteins by Mass Spectrometry
Daniel C. Liebler et al.
BIOCHEMISTRY (2013)
Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates
Yong Seok Choi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Recent advances in quantitative neuroproteomics
George E. Craft et al.
METHODS (2013)
Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation
Richard J. Perrin et al.
PLOS ONE (2013)
Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
Rongzhen Luo et al.
PLOS ONE (2013)
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease
Jere E. Meredith et al.
PLOS ONE (2013)
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions
Paola Picotti et al.
NATURE METHODS (2012)
A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid
Dorien Wijte et al.
METHODS (2012)
Novel Aβ Isoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment
Erik Portelius et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Sporadic cerebral amyloid angiopathy
J. Attems et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid
Adnan Halim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell et al.
BRAIN RESEARCH (2010)
Neurogranin, a Link Between Calcium/Calmodulin and Protein Kinase C Signaling in Synaptic Plasticity
F. Javier Diez-Guerra
IUBMB LIFE (2010)
An update on clinical proteomics in Alzheimer's research
Minna A. Korolainen et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity
Chung-Feng Hwang et al.
JOURNAL OF PATHOLOGY (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
TAR DNA-binding protein 43 in neurodegenerative disease
Alice S. Chen-Plotkin et al.
NATURE REVIEWS NEUROLOGY (2010)
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
John D. Andersen et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies
Tetsuaki Arai et al.
ACTA NEUROPATHOLOGICA (2009)
The Effect of Preanalytical Factors on Stability of the Proteome and Selected Metabolites in Cerebrospinal Fluid (CSF)
Therese Rosenling et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Identification of Novel APP/A beta Isoforms in Human Cerebrospinal Fluid
Erik Portelius et al.
NEURODEGENERATIVE DISEASES (2009)
Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags
Loic Dayon et al.
ANALYTICAL CHEMISTRY (2008)
Targeted proteomics in Alzheimer's disease: focus on amyloid-beta
Erik Portelius et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Proteomics of human neurodegenerative diseases
Jing Zhang et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Concomitant TAR-DNA-binding in Alzheimer disease and protein 43 pathology is present corticobasal degeneration but not in other tauopathies
Kunihiro Uryu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
A. H. Simonsen et al.
NEUROBIOLOGY OF AGING (2008)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
The receptor protein tyrosine phosphatase (RPTP)β/ζ is expressed in different subtypes of human breast cancer
Pablo Perez-Pinera et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
S. W. Scheff et al.
NEUROLOGY (2007)
Prediction of Alzheimer's disease using the CSF A beta 42/A beta 40 ratio in patients with mild cognitive impairment
Oskar Hansson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Genetics, transcriptomics, and proteomics of Alzheimer's disease
Andreas Papassotiropoulos et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Serum YKL-40, a new prognostic biomarker in cancer patients?
JS Johansen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
P Lewczuk et al.
NEUROBIOLOGY OF AGING (2004)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype
J Paloneva et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease
E Masliah et al.
NEUROLOGY (2001)
Tyrosine kinase signalling in breast cancer - Modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates
R Kairouz et al.
BREAST CANCER RESEARCH (2000)
分享论文
